Facebook Twitter LinkedIn YouTube Instagram

To navigate the following site navigation expect to utilize the tab key to move through items sequentially. The spacebar or enter keys can be utilized to interact with items that open sub-navigation.

The next tab will be the search box toggle. Hit enter to open the search, focus will automatically shift to the search bar. Type a letter into the search input and suggested results will appear.

Drug

BMD-MSCs

Status:

Phase 1

Condition:

Other ILD

Intervention Type:

Intravenous (IV) Injection

Funder Type:

Organization | University

Drug Details

Allogeneic Bone Marrow Derived Mesenchymal Stem Cells (BMD-MSCs)

Study Purpose

Researchers are trying to find out more about the safety of a new treatment, Allogeneic (coming from a healthy donor) Bone Marrow Derived Mesenchymal Stem Cells (BMD-MSCs) which is still experimental, for Interstitial Lung Disease (ILD) associated with Connective Tissue Disorder (CTD).

Find a Clinical Trial